HB22-1015
Off-label Use Of Approved Drugs To Treat COVID-19
| Type | Bill |
|---|---|
| Session | 2022 Regular Session |
| Subjects |
Concerning the ability of certain health-care providers to repurpose therapeutic drugs that have been approved by the federal food and drug administration for another purpose to provide treatment to individuals with COVID-19.
Bill Summary:
The bill specifies that:
- A physician, physician assistant, or advanced practice registered nurse with prescriptive authority may prescribe and dispense, and a pharmacist may dispense, therapeutic drugs for off-label use, including hydroxychloroquine sulfate and ivermectin, to provide prophylaxis or outpatient (at-home) and inpatient (hospital) treatment to an individual with COVID-19; and
- This practice is not unprofessional conduct or otherwise grounds for discipline.
(Note: This summary applies to this bill as introduced.)
Committees
House
Health & Insurance
If you require reasonable accessibility accommodation to access this content, please email accessibility@coleg.gov.
Related Documents & Information
| Date | Version | Documents |
|---|---|---|
| 01/12/2022 | Introduced |
| Date | Location | Action |
|---|---|---|
| 03/16/2022 | House | House Committee on Health & Insurance Postpone Indefinitely |
| 01/12/2022 | House | Introduced In House - Assigned to Health & Insurance |
Prime Sponsor
Sponsor
Co-Sponsor
(None)